Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises BICO in connection with a directed issue of new shares for SEK 2 billion
Mandate

Vinge advises BICO in connection with a directed issue of new shares for SEK 2 billion

October 08, 2021 Capital Markets and Public M&A

Vinge has advised BICO Group AB in connection with a directed issue of new shares for approximately SEK 2 billion.

The subscription price of SEK 480 was set pursuant to an accelerated bookbuilding procedure arranged by Carnegie, J.P. Morgan, ABG and Bryan Garnier. BICO intends to use the issue proceeds to finance the acquisition of QInstruments as well as to further promote the Company’s acquisition agenda and create financial preparedness regarding new possibilities.

Vinge’s team consisted of Anders Strid, Edin Agic and Adrian Filipovic.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025